UNcommon EGFR mutations: International Case series on efficacy of osimertinib in Real-life practice in first liNe setting (UNICORN).

J Bar,N Peled, S Schokrpur, M Wolner, O Rotem,N Girard,F Aboubakar Nana, S Derijcke,W Kian,S Patel, H Gantz-Sorotsky, A Zer,M Moskovitz,G Metro,Y Rottenberg,A Calles,M Hochmair,K Cuppens, L Decoster,M Reck, D Limon,E Rodriguez, C Astaras, A Bettini, S Häfliger,A Addeo

ANNALS OF ONCOLOGY（2022）

引用 25|浏览9

暂无评分

摘要

Osimertinib demonstrated activity in ucEGFRmut with high rate of disease control systemically and intracranially. Several resistance mechanisms were identified. This report comprises, to the best of our knowledge, the largest dataset of its kind.

查看译文

关键词

NSCLC,compound mutations,metastatic,uncommon EGFR mutation

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要